Title : Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

Pub. Date : 2009 Oct

PMID : 19247656






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Oxaliplatin tumor protein p53 Homo sapiens
2 CONCLUSION: Testing for p53 Arg72Pro, GSTP1 Ile105Val, and XRCC1 Arg399Gln polymorphisms may allow identification of gastric cancer patients who will benefit from oxaliplatin-based adjuvant chemotherapy. Oxaliplatin tumor protein p53 Homo sapiens